Document Detail


Isradipine dynamics and pharmacokinetics in the isolated rabbit heart.
MedLine Citation:
PMID:  1535129     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The cardiac effects of increasing concentrations of isradipine (racemic) from 1.64 pM to 232 nM were studied in isolated spontaneously beating rabbit hearts. Inhibitory responses with regard to contraction amplitude, contraction velocity and oxygen consumption exhibited a biphasic progressive course at increasing drug exposure. Computer derived inhibitory Emax-values of the second phase were 104, 103 and 87% (IC50: 7.1, 6.3 and 28.7 nM), respectively, whereas those of the initial phase were 24.7, 25.9 and 19.5% (IC50: 0.012, 0.038 and 0.026 nM). A progressive inhibition of frequency reached a maximum of only 21%. The ECG-derived PQ-interval showed a rapid increase (maximum 46%) at drug concentrations above 1 nM. Complete AV-block and ventricular asystolia occurred in half of the hearts at the second highest (99 nM) and in all except one at the highest concentration. SA-node activity was retained in 9 of 10 hearts at the second highest and in 3 at the highest drug exposure. The QRS-and the frequency-corrected QT-interval did not increase significantly. Coronary flow-rate showed no initial increase, but a decrease to 70% of control at the highest concentration. Supplementary in vitro studies on rabbit coronary artery ring-preparations contracted with 124 mM K+ showed, however, an relaxant Emax-value for isradipine of about 100% and an inhibitory EC50-value of 0.63 nM with a 'Hill' coefficient of 1.1. At toxic concentrations isradipine showed a kinetic monophasic accumulation in the rabbit heart of about 44-fold with a half-time of 10.6 min.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S Mellemkjaer; L Bang; F Nielsen-Kudsk
Related Documents :
11021469 - Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de...
17287589 - Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block ...
19305409 - Common variants at ten loci modulate the qt interval duration in the qtscd study.
16884519 - Idiopathic polymorphic ventricular tachycardia with normal qt interval in a structurall...
19808499 - Clinical correlates and heritability of qt interval duration in blacks: the jackson hea...
11583899 - Pause-dependent torsade de pointes following acute myocardial infarction: a variant of ...
1892239 - The influence of cls 2210 on the course of myocardial infarction: a pilot study in man.
20304839 - Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events ...
1293119 - Obstructive enterolith in an 11-month-old miniature horse.
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Pharmacology & toxicology     Volume:  70     ISSN:  0901-9928     ISO Abbreviation:  Pharmacol. Toxicol.     Publication Date:  1992 May 
Date Detail:
Created Date:  1992-07-23     Completed Date:  1992-07-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8702180     Medline TA:  Pharmacol Toxicol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  366-72     Citation Subset:  IM    
Affiliation:
Institute of Pharmacology, University of Aarhus, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Calcium Channel Blockers / administration & dosage,  pharmacokinetics*,  pharmacology*
Coronary Circulation / drug effects
Dihydropyridines / administration & dosage,  pharmacokinetics*,  pharmacology*
Electrocardiography / drug effects
Female
Heart / drug effects*
Heart Rate / drug effects
Isradipine
Male
Myocardial Contraction / drug effects
Myocardium / metabolism
Rabbits
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 0/Dihydropyridines; 75695-93-1/Isradipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Failure of epinephrine to induce severe cardiac arrhythmia in rats with ventricular hypertrophy seco...
Next Document:  Pelvic and para-aortic lymphadenectomy in primary cancer of the ovary